Search - tctmd.com

Displaying 321 - 340 of 2421

Sort: Relevancy | Date

Presentation TCT 2020

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

Presenter: Takeshi Nishi

October 14, 2020

Presentation TCT 2020

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

Presenter: Bernardo Cortese

October 14, 2020

Presentation TCT 2020

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

Presenter: Ian Brian Alexander Menown

October 14, 2020

Presentation TCT 2020

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 14, 2020

Presentation TCT 2020

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

Presenter: Jian Tian

October 14, 2020

Presentation TCT 2020

TCT 247: Outcomes of Percutaneous Coronary Intervention in Cardiac Transplant Patients: A Bi-national Analysis Derived From the United Kingdom and United States

Presenter: Vinayak Nagaraja

October 14, 2020

Presentation TCT 2020

TCT 274: Adaptive Coronary Rotation in the Drug-Eluting Bioadaptor With Uncaging Segments Reduces Stress on the Coronary Artery

Presenter: Mayank Kansal

October 14, 2020

Presentation TCT 2020

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

Presenter: Sridhar Kasturi, MD

October 14, 2020

Presentation TCT 2020

TCT 251: Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis

Presenter: Mohamed Farag

October 14, 2020

Presentation TCT 2020

TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation

Presenter: Tatsuhiro Fujimura

October 14, 2020

Presentation TCT 2020

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Presenter: Matthias Lutz

October 14, 2020

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

Presentation JIM 2020

Supraflex Cruz in the challenging scenario of older MI patients

Presenter: Gianluca Campo

February 13, 2020

Presentation JIM 2020

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

Presenter: Bernardo Cortese

February 13, 2020

Presentation

“Is Sirolimus the new concept for Drug Coated Balloon?”

Presenter: Bernardo Cortese

February 13, 2020

Presentation JIM 2020

When the artery is highly calcified: and inside look using the best tool

Presenter: Francesco Prati

February 13, 2020

Advertisement

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

TCT 247: Outcomes of Percutaneous Coronary Intervention in Cardiac Transplant Patients: A Bi-national Analysis Derived From the United Kingdom and United States

TCT 274: Adaptive Coronary Rotation in the Drug-Eluting Bioadaptor With Uncaging Segments Reduces Stress on the Coronary Artery

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

TCT 251: Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis

TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

The Abluminus DES+: from the technical features to the clinical program

Supraflex Cruz in the challenging scenario of older MI patients

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

“Is Sirolimus the new concept for Drug Coated Balloon?”

When the artery is highly calcified: and inside look using the best tool

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content